A pathogenic role for NKG2D was reported by Ogasawara et al. (36), who demonstrated that antibody-mediated blocking of NKG2D signaling led to reduced infiltration of autoreactive CD8+ T cells into the pancreas of 16-week-old NOD mice and decreased diabetes incidence. Here, KLRK1 is linked to diabetes mellitus.